Cluster sell at Rocket Pharmaceuticals, Inc.: three insiders sell $155,141 of RCKT
Open-market sales between Nov 5 and Nov 13, none marked as part of a 10b5-1 plan. Information only, not investment advice.
Three insiders at Rocket Pharmaceuticals, Inc. (RCKT) sold shares on the open market between Nov 5 and Nov 13, a combined $155,141, according to Form 4 filings with the SEC.
Martin Wilson (general counsel) made the largest sale, $127,813 at an average of $2.39 a share. The table below lists who sold, when, and at what price.
Gaurav Shah (CEO) is the latest to report, in a filing on Nov 17. None of these filings marks the sale as made under a Rule 10b5-1 trading plan.
The numbers below are taken from the Form 4 as filed with the SEC.
| Insider | Role | Trade date | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| Martin Wilson | General Counsel | Nov 5 | 53,389 | $2.39 | $127,813 | App · SEC |
| Sarbani Chaudhuri | Officer | Nov 9 | 4,872 | $2.33 | $11,337 | App · SEC |
| Martin Wilson | General Counsel | Nov 13 | 4,087 | $2.25 | $9,196 | App · SEC |
| Gaurav Shah | CEO | Nov 13 | 3,020 | $2.25 | $6,795 | App · SEC |
| Total | $155,141 |
Each row of the table links to its Form 4 on SEC.gov.
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.